APA (7th ed.) Citation

MS, C., KR, G., AL, N., & BS, S. (2020). Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells. Translational lung cancer research, 9(5), 1904. https://doi.org/10.21037/tlcr-20-522

Chicago Style (17th ed.) Citation

MS, Clement, Gammelgaard KR, Nielsen AL, and Sorensen BS. "Epithelial-to-mesenchymal Transition Is a Resistance Mechanism to Sequential MET-TKI Treatment of MET-amplified EGFR-TKI Resistant Non-small Cell Lung Cancer Cells." Translational Lung Cancer Research 9, no. 5 (2020): 1904. https://doi.org/10.21037/tlcr-20-522.

MLA (9th ed.) Citation

MS, Clement, et al. "Epithelial-to-mesenchymal Transition Is a Resistance Mechanism to Sequential MET-TKI Treatment of MET-amplified EGFR-TKI Resistant Non-small Cell Lung Cancer Cells." Translational Lung Cancer Research, vol. 9, no. 5, 2020, p. 1904, https://doi.org/10.21037/tlcr-20-522.